As interest continues to grow in high flow oxygen therapy, an increasing number of reports on this alternative to conventional oxygen therapy can be found in the literature. We have summarized the key data from more than 30 publications in our new bibliography.
Mortara Instrument, Inc. Announces FDA 510(k) Clearance to Market Its Multi-Modality DICOM Review Toolset for Resting ECG, Stress and Holter
CardioConfirm, the latest innovation from a leading U.S. medical device manufacturer
Mortara Instrument, Inc. Announces Expansion of ECG Warehouse Contract Award with the U.S. FDA
Mortara to provide ongoing support for FDA ECG Warehouse including continuous ECG studies analyzed by VERITAS™.